LCE 75 (Carbidopa, Entacapone and Levodopa 18.75 mg / 200 mg / 75 mg)
Pill with imprint LCE 75 is Red, Elliptical / Oval and has been identified as Carbidopa, Entacapone and Levodopa 18.75 mg / 200 mg / 75 mg. It is supplied by Sandoz Inc.
Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 18.75 mg / 200 mg / 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LCE 75
Carbidopa, Entacapone and Levodopa
- Imprint:
- LCE 75
- Strength:
- 18.75 mg / 200 mg / 75 mg
- Color:
- Red
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sandoz Inc
- National Drug Code (NDC):
- 00781-5625
More about carbidopa/entacapone/levodopa
- Carbidopa/entacapone/levodopa Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 7 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
- Carbidopa, entacapone, and levodopa
- Levodopa, Carbidopa, and Entacapone
- Carbidopa, entacapone, and levodopa (Advanced Reading)
Other brands: Stalevo, Stalevo 150, Stalevo 100, Stalevo 125, ... +3 more
Professional resources
- Carbidopa, Levodopa and Entacapone (FDA)
- Carbidopa, Levodopa and Entacapone Tablets (FDA)
- Levodopa, Carbidopa, and Entacapone (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
